Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
60 Degrees Pharmaceuticals Inc
SXTP
Healthcare
Biotechnology
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under...
development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SXTP)
New Post
View:
Posts & Comments
Threaded Posts
(215)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 08, 2025 8:39am
Buy buddy buy.
From the day trading establishment.
(59)
•••
Nibinator
X
Post by
Nibinator
on Jul 25, 2024 1:14pm
BUY BUY BUY BUY BUY
About to blow the lid off the top
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 19, 2024 8:57am
RE:RE:SXTP....early a.m runner up on no News
Dang ....forgot to post the NR.... 60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study 2024-07-19 05:29
...more
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 19, 2024 8:57am
RE:SXTP....early a.m runner up on no News
Excuse me.....there was a NR at 5:30....just as I was posting my last post. Regardless.......fluff news......Ya pays yo money and yo takes yo chances
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 19, 2024 8:36am
SXTP....early a.m runner up on no News
The Market Maker is calling all the Retail Chasers to get on board.....because he has lots of paer to flog to them at inflated prices just so he can short the financing to the insuspected. Currently
...more
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 21, 2023 2:42pm
SXTP....Thru RBL....next support at 92 cents
Just in case your wondering
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 21, 2023 2:03pm
SXTP.....False alarm !
Going no where ....fast
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This company is set to benefit from a change in Ontario legislation
How Web3 Will Fundamentally Reshape Finance
Largest integrated facility services provider in Canada releases financial results for Q1, 2025